.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Teva
Julphar
Medtronic
Fish and Richardson
Healthtrust
McKesson
Cerilliant
Colorcon

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,114,313

« Back to Dashboard

Which drugs does patent 6,114,313 protect, and when does it expire?


Patent 6,114,313 protects KENGREAL and is included in one NDA.

This patent has thirty-nine patent family members in thirty-two countries.

Summary for Patent: 6,114,313

Title: Pharmaceutical compositions for freeze drying
Abstract:A pharmaceutical composition comprising a nucleotide analogue, mannitol and a modifying additive which is sodium chloride or a polyol which is suitable for freeze drying.
Inventor(s): Bland; Chris (Leics, GB), Steele; Gerald (Leics, GB)
Assignee: Astra Zeneca UK Limited (London, GB)
Application Number:09/043,159
Patent Claim Types:
see list of patent claims
Composition; Compound; Process; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Chiesi Usa Inc
KENGREAL
cangrelor
POWDER;IV (INFUSION)204958-001Jun 22, 2015RXYesYes► Subscribe► SubscribeY P2Y12 PLATELET INHIBITOR FOR USE AS ADJUNCT TO PERCUTANEOUS CORONARY INTERVENTIONTO REDUCE RISK OF VARIOUS DISEASES/CONDITIONS IN PATIENTS NOT TREATED WITH A P2Y12 PLATELET INHIBITOR AND NOT GIVEN A GLYCOPROTEIN IIB/IIIA INHIBITOR
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,114,313

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9604795Dec 20, 1996
PCT Information
PCT FiledDecember 11, 1997PCT Application Number:PCT/SE97/02068
PCT Publication Date:July 02, 1998PCT Publication Number: WO98/28009

International Patent Family for Patent: 6,114,313

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China1121875► Subscribe
Czech Republic9902201► Subscribe
Czech Republic300635► Subscribe
Germany69714616► Subscribe
Denmark1007094► Subscribe
Estonia9900260► Subscribe
Estonia03857► Subscribe
European Patent Office1007094► Subscribe15C0060France► Subscribe
Spain2182133► Subscribe
Hong Kong1026366► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Daiichi Sankyo
Queensland Health
QuintilesIMS
Moodys
Fuji
Medtronic
Novartis
Covington
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot